Oncology
Flowchart Overview
 
2
1
1
2
1
2
1
IIT-GEORGE-I-PREDICT Phase I/II OPEN TO ACCRUAL
3
4
1
6
CELGENE-GC-LTFU-001 Phase II/III OPEN TO ACCRUAL
GRACELL-GC012F-CD19-BCMA-001 Phase I/II OPEN TO ACCRUAL
GSK-3377794-LTFU Phase I OPEN TO ACCRUAL
IIT-SHAH-IL7-IL15-CD20-19 Phase I/II OPEN TO ACCRUAL
JNJ-MY4002-CARTINUE-LTFU Phase IV OPEN TO ACCRUAL
JUNO-017004-TRANSCEND-CLL Phase I/II OPEN TO ACCRUAL
1
TRANSTHERA-TT420C2308 Phase III OPEN TO ACCRUAL
1
1
2
1
1
3
1
2
2
2
5
5
3
1
2
2
1
2
5
3
3
1
2
1
MAYO-ECHO-STUDY Phase II OPEN TO ACCRUAL
1
3
3
1
3
2
1
3
1
3
1
1
3
2
1
2
2
2
3
1
1
1
3
3
1
1
3
7
1
1
1
3
ECOG-EA4232 Phase III OPEN TO ACCRUAL
LILLY-J2N-MC-JZNY Phase IV OPEN TO ACCRUAL
SWOG-MM1YA-S01 Phase II OPEN TO ACCRUAL
18
1
2
1
2
9
4
4
2
5
5
2
1
1
1
1
13
4
9
3
2
1
6
1
3
4
4
2
3
3
1
2
2
11
2
2
1
5
1
1
1
1
2
2
2
1
2
1
1
1
IIT-GORE-REDIRICT Phase II OPEN TO ACCRUAL
4
1
1
1
3
8
5
1
1
2
CARNABIOSCIENCES-C1763102 Phase I OPEN TO ACCRUAL
IIT-GORE-REDIRICT Phase II OPEN TO ACCRUAL
14
13
3
2
2
1
1
1
4
3
3
3
1
3
3
1
3
3
1
3
3
1
3
3
1
2
2
1
1
8
5
4
1
1
1
1
2
1
1
2
1
3
3
7
3
5
5
3
1
11
1
6
1
IIT-GEORGE-I-PREDICT Phase I/II OPEN TO ACCRUAL
1
ALLIANCE-A151804 Phase N/A OPEN TO ACCRUAL